1. Technology Title One-line Description Name, PhD Title Department
Rutgers University
Name2, PhD; Title
Name3, PhD; Title

2. Introduction
“Elevator pitch” – a simple mission statement, no more than 2-3 sentences, that encapsulates:
What your technology is and how it works, in “plain English”;
What specific problem it solves;
Why your technology is unique and superior; and
Who actually uses your product (if appropriate).
A picture or diagram of your technology, if appropriate.
This slide should be crafted for a generalist and non-scientist.

3. Problem & Market Need
What is the unmet market need? What is the problem you are trying to solve?
What is the estimated market size specific to your technology?

4. The Innovation - Summary
Visual display of your product/service.
What does it do?
How does it solve the market need?
Compare and contrast to current solutions/gold standard.
How is your solution unique?
What are the advantages?
What are the risks and dis-advantages?

5. The Innovation - Details Part 1
Describe one specific aspect or improvement that your technology offers (i.e., one aspect per slide).
Include supporting data, evidence, charts, as appropriate.

6. The Innovation - Details Part 2 (3 additional slides, max)
Describe a specific aspect / improvement that your technology offers.
Include supporting data, evidence, charts, as appropriate.

7. Current Stage of Development
What is the IP/patent status?
Other than Rutgers, what other institution(s), if any, co-own(s) the technology?
What is the current stage of the technology? i.e., “Where are you today?”
E.g., “We achieved …” or “We discovered that …”
E.g., “Our lead compounds exhibit …”
E.g., “We have a working prototype that does ...”
E.g., “We are ready to perform …”
E.g., “We identified partners to help manufacture components of …”
This section should include a combination of the above, and serves as a segue to the next slide.

8. Goals & Milestones – (See Next Slide for an example)
Near-term goals (next steps to validate commerciality)
Experiments, MVP (minimum viable product)
Customer discovery exercises
Gaps to be addressed with current round of funding:
What will this funding help you achieve?
What meaningful results do you expect to generate?
What aspect of the technology are you “de-risking” (e.g., toxicity, efficacy, etc.)
Multi-year timeline of product development to commercialization.
E.g., pre-clinical, clinical, product launch.
What key research needs to be done at each stage?
What specifically are you “de-risking” at each stage?
How much (further) funding is likely required at each stage. (Optional)
This sub-section would be helpful if the tech requires materially different funding or timeline of development compared to “standard” regulatory processes.
Are there other broader potential fields of use or commercialization aspects for this technology?

9. Development Timeline & Funding Requirements
General Template for life-sciences. Please note that ALL the numbers and comments are placeholders, and should be modified to be directly relevant to your technology.
Development Timeline & Funding Requirements
Key Tasks & Milestones:
Discovery & Lead Optimization
In vivo testing:
Mice (n=12)
Efficacy
Dose range
Toxicity
Commentary on head-to-head comparison to gold standard
Large animal model
Pig (n=10)
Characterize production steps for lead compounds
CRO: candidate list and initiate contact
Other commentary
Pre-IND filing
IND-enabling studies
Establish GMP
Quality attributes
Engage CROs and CMOs
Other commentary
Phase 1
Human trials (n= )
General commentary
Timeline:
6-12 months
12 months
9-12 months
2-3 years
3Q19
2Q20
2Q21
2Q22
Funding
Required:
$250K
$350K
$3M
$20M+
Cumulative:
$250K
$600K
$3.6M
$30M
(SBIR I, NIH, Angel/Seed)
(SBIR II, Angel/Seed, VC)
(VC)
(VC / IPO)
Other Notables:
Cumulative Funding To-Date:
NIH (2015 – 3Q 2019: $1M)
Rutgers TechAdvance (1Q 2019: $100K)

10. The Team Include pictures of team members, if appropriate.
If possible, highlight skillsets and knowledge base that are complementary.
An ideal team would have: Scientific expertise, Clinical expertise, Commercialization expertise.
Include a “Commercialization Track Record”, if any, as a separate slide:
A summary highlight of products that your team was directly involved with, that are currently (1) commercial, (2) in development, and/or (3) in clinical studies or use.
If you have a truly unique team and track record (successful commercialization, seasoned business founders, expert clinicians, etc.), this slide could be the first or second slide of the presentation.

11. THANK YOU

12. Appendix (multiple slides as appropriate)
More data and evidence supporting your technology.
More details on market size, segments of the market, and opportunity.